VIBERZI

Abbvie Corporation🇨🇦 Health Canada

Approval Id: 142ff21ba18f1ecc
Drug Approval Canada Name: VIBERZI
Product Name: VIBERZI
Status: Marketed
Status Date: 2025-06-09
Original Market Date: 2017-04-24
Din: 02460890
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 56:92.00
Atc Original: A07DA06 ELUXADOLINE
Atc Name: a 07 da 06
Aig Number: 0158810001
Company Name: Abbvie Corporation
Company Address: 8401 Trans-Canada Highway, Saint-Laurent, Quebec, Canada, H4S 1Z1
Company Detail Path: /organization/abbvie-corporation

ELUXADOLINE

75 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

142ff21ba18f1ecc

Type

Standard